Drawing for LAQUESA

USPTO serial 85259993

LAQUESA

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
MCBRIDE, THEODORE M
Law office
OFFICE OF TRADEMARK PROGRAM CONTROL

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with LAQUESA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of Multiple Sclerosis, Lupus Nephritis and Crohn's diseaseABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 18, 2011MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION—
Oct 18, 2011ABN5ABANDONMENT - AFTER PUBLICATION—
Sep 7, 2011EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Aug 18, 2011ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jul 26, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 26, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 10, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 7, 2011DOCKASSIGNED TO EXAMINER—
Mar 10, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 10, 2011NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance